Literature DB >> 19995845

HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.

Doralina Guimaraães Brum1, Amilton Antunes Barreira, Antonio Carlos dos Santos, Damacio Ramon Kaimen-Maciel, Marcelo Matiello, Roberta Martins Costa, Neifi Hassan Saloun Deghaide, Laudo Silva Costa, Paulo Louzada-Junior, Paula Rejane Beserra Diniz, Elizabeth Regina Comini-Frota, Celso Teixeira Mendes-Junior, Eduardo Antonio Donadi.   

Abstract

Until recently, neuromyelitis optica (NMO) was considered to be a sub-type of multiple sclerosis (MS), which has a strong predilection for Caucasian populations, whereas NMO is more frequent in non-Caucasian individuals. The objective of this study was to compare the HLA-DRB profile in Brazilian Mulatto patients with NMO spectrum disorders (NMOSDs) with that observed for Mulatto MS patients and healthy Mulatto controls. Twenty seven NMOSD patients (20 women), all seropositive for NMO-IgG, 29 MS patients and 28 Mulatto healthy blood donors were evaluated for HLA-DRB allele groups. HLA-DRB1*03 allele group was overrepresented in NMO patients compared with healthy controls (p = 0.0401; OR = 3.23, 95%CI: 1.07-9.82). In contrast, the HLA-DRB1*15 allele group was overrepresented in Brazilian MS patients (OR = 15.89, 95%CI: 3.51-71.85; p < 0.0001). DRB3 was overrepresented in NMO (p = 0.0064), and DRB5 overrepresented in MS patients (p = 0.0001). The low frequency of HLA-DRB1*15 alleles was associated with the presence of long and central cord lesions at magnetic resonance. In addition, DRB1*15 alleles were associated with the fulfillment of the Barkhof criteria. In conclusion, these results indicate that the DRB profile of NMO patients is different from that observed for MS patients, further corroborating the distinction between NMO and MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995845     DOI: 10.1177/1352458509350741

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  39 in total

Review 1.  The adaptive immune system in diseases of the central nervous system.

Authors:  David C Wraith; Lindsay B Nicholson
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

3.  Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica.

Authors:  Benjamine Arellano; Rehana Hussain; Tresa Zacharias; Jane Yoon; Chella David; Sima Zein; Lawrence Steinman; Thomas Forsthuber; Benjamin M Greenberg; Doris Lambracht-Washington; Alanna M Ritchie; Jeffrey L Bennett; Olaf Stüve
Journal:  Arch Neurol       Date:  2012-09

4.  Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.

Authors:  Sharon A Sagan; Ryan C Winger; Andrés Cruz-Herranz; Patricia A Nelson; Sarah Hagberg; Corey N Miller; Collin M Spencer; Peggy P Ho; Jeffrey L Bennett; Michael Levy; Marc H Levin; Alan S Verkman; Lawrence Steinman; Ari J Green; Mark S Anderson; Raymond A Sobel; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

Review 5.  Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Authors:  Meike Mitsdoerffer; Vijay Kuchroo; Thomas Korn
Journal:  Ann N Y Acad Sci       Date:  2013-04       Impact factor: 5.691

Review 6.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

Review 7.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

8.  Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.

Authors:  Michel Varrin-Doyer; Collin M Spencer; Ulf Schulze-Topphoff; Patricia A Nelson; Robert M Stroud; Bruce A C Cree; Scott S Zamvil
Journal:  Ann Neurol       Date:  2012-07-17       Impact factor: 10.422

Review 9.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

10.  Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics.

Authors:  Iris Grossman; Ariel Miller
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.